Use of Standardization of Uveitis Nomenclature for Reporting Clinical Data at 10 Years

Genevieve Oliver; Roy Stathis; Nicola Spurrier; Justine Smith

doi:10.1016/j.ophtha.2017.03.009

Use of Standardization of Uveitis Nomenclature for Reporting Clinical Data at 10 Years

Genevieve Oliver, Roy Stathis, Nicola Spurrier, Justine Smith

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

1 Downloads (Pure)

Abstract

Uveitis is a heterogeneous group of infectious and noninfectious intraocular inflammatory diseases. Management of both subsets of uveitis is frequently challenging. Since 2000, advances in microbial diagnostics and introduction of biologic drugs, combined with the potential for electronic communication to facilitate research on diseases with low incidence, have provided uveitis specialists with unprecedented opportunities for clinical trials to establish evidence-based management algorithms. Hampering this effort, however, was lack of a common system for describing uveitis, including diagnosis, severity, and outcome.

Original language	English
Pages (from-to)	1084-1085
Number of pages	2
Journal	Ophthalmology
Volume	124
Issue number	7
Early online date	31 Mar 2017
DOIs	https://doi.org/10.1016/j.ophtha.2017.03.009
Publication status	Published - Jul 2017

Keywords

Uveitis
Nomenclature
Inflammatory diseases

Access to Document

10.1016/j.ophtha.2017.03.009Licence: In Copyright

Oliver_Use_AM2017Accepted author manuscript, 411 KBLicence: CC BY-NC-ND
Oliver_Table1_AM2017Accepted author manuscript, 382 KBLicence: CC BY-NC-ND
Oliver_Table2_AM2017Accepted author manuscript, 478 KBLicence: CC BY-NC-ND

Fingerprint Dive into the research topics of 'Use of Standardization of Uveitis Nomenclature for Reporting Clinical Data at 10 Years'. Together they form a unique fingerprint.

Cite this

@article{b250c97edd3c4a90be29fad4da87d6a4,

title = "Use of Standardization of Uveitis Nomenclature for Reporting Clinical Data at 10 Years",

abstract = "Uveitis is a heterogeneous group of infectious and noninfectious intraocular inflammatory diseases. Management of both subsets of uveitis is frequently challenging. Since 2000, advances in microbial diagnostics and introduction of biologic drugs, combined with the potential for electronic communication to facilitate research on diseases with low incidence, have provided uveitis specialists with unprecedented opportunities for clinical trials to establish evidence-based management algorithms. Hampering this effort, however, was lack of a common system for describing uveitis, including diagnosis, severity, and outcome.",

keywords = "Uveitis, Nomenclature, Inflammatory diseases",

author = "Genevieve Oliver and Roy Stathis and Nicola Spurrier and Justine Smith",

year = "2017",

month = jul,

doi = "10.1016/j.ophtha.2017.03.009",

language = "English",

volume = "124",

pages = "1084--1085",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Use of Standardization of Uveitis Nomenclature for Reporting Clinical Data at 10 Years

AU - Oliver, Genevieve

AU - Stathis, Roy

AU - Spurrier, Nicola

AU - Smith, Justine

PY - 2017/7

Y1 - 2017/7

N2 - Uveitis is a heterogeneous group of infectious and noninfectious intraocular inflammatory diseases. Management of both subsets of uveitis is frequently challenging. Since 2000, advances in microbial diagnostics and introduction of biologic drugs, combined with the potential for electronic communication to facilitate research on diseases with low incidence, have provided uveitis specialists with unprecedented opportunities for clinical trials to establish evidence-based management algorithms. Hampering this effort, however, was lack of a common system for describing uveitis, including diagnosis, severity, and outcome.

AB - Uveitis is a heterogeneous group of infectious and noninfectious intraocular inflammatory diseases. Management of both subsets of uveitis is frequently challenging. Since 2000, advances in microbial diagnostics and introduction of biologic drugs, combined with the potential for electronic communication to facilitate research on diseases with low incidence, have provided uveitis specialists with unprecedented opportunities for clinical trials to establish evidence-based management algorithms. Hampering this effort, however, was lack of a common system for describing uveitis, including diagnosis, severity, and outcome.

KW - Uveitis

KW - Nomenclature

KW - Inflammatory diseases

UR - http://purl.org/au-research/grants/arc/FT130101648

U2 - 10.1016/j.ophtha.2017.03.009

DO - 10.1016/j.ophtha.2017.03.009

M3 - Article

VL - 124

SP - 1084

EP - 1085

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 7

ER -

Use of Standardization of Uveitis Nomenclature for Reporting Clinical Data at 10 Years

Abstract

Keywords

Access to Document

Other files and links

Cite this